CO5560569A2 - Productos de combinacion de derivados de propanolamina arilo sustituidos con otros ingredientes activos y su uso - Google Patents
Productos de combinacion de derivados de propanolamina arilo sustituidos con otros ingredientes activos y su usoInfo
- Publication number
- CO5560569A2 CO5560569A2 CO04014409A CO04014409A CO5560569A2 CO 5560569 A2 CO5560569 A2 CO 5560569A2 CO 04014409 A CO04014409 A CO 04014409A CO 04014409 A CO04014409 A CO 04014409A CO 5560569 A2 CO5560569 A2 CO 5560569A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- residue
- amino acid
- cho
- phenyl
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 150000001720 carbohydrates Chemical group 0.000 abstract 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000000600 disaccharide group Chemical group 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 150000004044 tetrasaccharides Chemical group 0.000 abstract 2
- 150000004043 trisaccharides Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- -1 alkyl radicals Chemical class 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 229910052736 halogen Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10140170A DE10140170A1 (de) | 2001-08-22 | 2001-08-22 | Kombinationspräparate von arylsubstituierten Propanolaminderivaten mit weiteren Wirkstoffen und deren Verwendung |
| DE2001142455 DE10142455A1 (de) | 2001-08-31 | 2001-08-31 | Kombinationspräparate von arylsubstituierten Propanolderivaten mit weiteren Wirkstoffen und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5560569A2 true CO5560569A2 (es) | 2005-09-30 |
Family
ID=26009945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04014409A CO5560569A2 (es) | 2001-08-22 | 2004-02-19 | Productos de combinacion de derivados de propanolamina arilo sustituidos con otros ingredientes activos y su uso |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20030158094A1 (enExample) |
| EP (1) | EP1420826A2 (enExample) |
| JP (1) | JP2005505538A (enExample) |
| KR (1) | KR20040027963A (enExample) |
| CN (1) | CN1638801A (enExample) |
| AR (1) | AR035284A1 (enExample) |
| BR (1) | BR0211995A (enExample) |
| CA (1) | CA2457974A1 (enExample) |
| CO (1) | CO5560569A2 (enExample) |
| HR (1) | HRP20040172A2 (enExample) |
| HU (1) | HUP0401908A2 (enExample) |
| IL (1) | IL160475A0 (enExample) |
| MX (1) | MXPA04001256A (enExample) |
| NO (1) | NO20040726L (enExample) |
| NZ (1) | NZ531292A (enExample) |
| PA (1) | PA8553101A1 (enExample) |
| PE (1) | PE20030358A1 (enExample) |
| PL (1) | PL366855A1 (enExample) |
| RU (1) | RU2004108120A (enExample) |
| UY (1) | UY27418A1 (enExample) |
| WO (1) | WO2003018059A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| IL156445A0 (en) | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| KR20070120617A (ko) | 2001-01-26 | 2007-12-24 | 쉐링 코포레이션 | 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물 |
| EP1429756B1 (en) | 2001-09-21 | 2006-11-22 | Schering Corporation | Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| CA2504916A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| DE602004018617D1 (de) | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| WO2004081004A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023245A (en) * | 1987-11-10 | 1991-06-11 | Hauser-Kuhrts, Inc. | Improved niacin formulation |
| DE19845402B4 (de) * | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| ATE268758T1 (de) * | 1997-04-04 | 2004-06-15 | Aventis Pharma Gmbh | Hypolipidämische propanolaminderivate |
| DE19845405C2 (de) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| DE19845406C2 (de) * | 1998-10-02 | 2001-10-18 | Aventis Pharma Gmbh | Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE69911058T2 (de) * | 1998-12-23 | 2004-06-03 | G.D. Searle Llc, Chicago | Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen |
-
2002
- 2002-08-09 JP JP2003522574A patent/JP2005505538A/ja active Pending
- 2002-08-09 EP EP02796212A patent/EP1420826A2/de not_active Withdrawn
- 2002-08-09 CA CA002457974A patent/CA2457974A1/en not_active Abandoned
- 2002-08-09 NZ NZ531292A patent/NZ531292A/en unknown
- 2002-08-09 HU HU0401908A patent/HUP0401908A2/hu unknown
- 2002-08-09 IL IL16047502A patent/IL160475A0/xx unknown
- 2002-08-09 BR BR0211995-1A patent/BR0211995A/pt not_active IP Right Cessation
- 2002-08-09 CN CNA028163532A patent/CN1638801A/zh active Pending
- 2002-08-09 PL PL02366855A patent/PL366855A1/xx not_active Application Discontinuation
- 2002-08-09 WO PCT/EP2002/008907 patent/WO2003018059A2/de not_active Ceased
- 2002-08-09 KR KR10-2004-7002542A patent/KR20040027963A/ko not_active Withdrawn
- 2002-08-09 RU RU2004108120/15A patent/RU2004108120A/ru not_active Application Discontinuation
- 2002-08-09 HR HR20040172A patent/HRP20040172A2/hr not_active Application Discontinuation
- 2002-08-09 MX MXPA04001256A patent/MXPA04001256A/es unknown
- 2002-08-16 PE PE2002000744A patent/PE20030358A1/es not_active Application Discontinuation
- 2002-08-20 AR ARP020103123A patent/AR035284A1/es not_active Application Discontinuation
- 2002-08-20 UY UY27418A patent/UY27418A1/es unknown
- 2002-08-20 PA PA20028553101A patent/PA8553101A1/es unknown
- 2002-08-22 US US10/225,802 patent/US20030158094A1/en not_active Abandoned
-
2004
- 2004-02-19 CO CO04014409A patent/CO5560569A2/es not_active Application Discontinuation
- 2004-02-19 NO NO20040726A patent/NO20040726L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0211995A (pt) | 2004-09-28 |
| MXPA04001256A (es) | 2004-05-27 |
| RU2004108120A (ru) | 2005-04-10 |
| PL366855A1 (en) | 2005-02-07 |
| HRP20040172A2 (en) | 2004-10-31 |
| PA8553101A1 (es) | 2003-06-30 |
| CA2457974A1 (en) | 2003-03-06 |
| NO20040726L (no) | 2004-02-19 |
| JP2005505538A (ja) | 2005-02-24 |
| HUP0401908A2 (hu) | 2005-01-28 |
| EP1420826A2 (de) | 2004-05-26 |
| UY27418A1 (es) | 2002-11-29 |
| KR20040027963A (ko) | 2004-04-01 |
| PE20030358A1 (es) | 2003-04-23 |
| CN1638801A (zh) | 2005-07-13 |
| US20030158094A1 (en) | 2003-08-21 |
| IL160475A0 (en) | 2004-07-25 |
| AR035284A1 (es) | 2004-05-05 |
| WO2003018059A3 (de) | 2003-11-13 |
| NZ531292A (en) | 2005-08-26 |
| WO2003018059A2 (de) | 2003-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
| AR035631A1 (es) | Compuestos quimicos | |
| AR035320A1 (es) | Compuestos activadores de hppardelta, composicion farmaceutica, su uso en la preparacion de medicamentos, metodo para el tratamiento de enfermedades mediadas por hppardelta | |
| NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
| AR029634A1 (es) | Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento | |
| AR033525A1 (es) | Arilmetilaminas sustituidas, composiciones farmaceuticas, uso de las mismas para la manufactura de un medicamento | |
| PE20030358A1 (es) | Formulacion en combinacion de derivados de propanol amina sustituidos con arilo, junto con otras sustancias activas | |
| ES2187983T3 (es) | Derivados 1,2,3,4-tetrahidronaftaleno sustituidos. | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| ES2191475T3 (es) | Conjugados de prostaglandina para el tratamiento o prevencion de enfermedades oseas. | |
| AR032607A1 (es) | Composiciones farmaceuticas que contienen sales de hidroxieicosatetraenoato, y el uso de las mismas para la manufactura de un medicamento para el tratamiento de desordenes del ojo seco | |
| WO2005066167A3 (en) | 3-quinuclidinyl heteroatom bridged biaryl derivatives | |
| NO20022124L (no) | Imidazopyridinderivater som fosfodiesterase VII-inhibitorer | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| NO20083448L (no) | Benzo(f)isoindol-2-ylfenyleddiksyrederivater som EP4 receptoragonister | |
| AR039935A1 (es) | Formulacion farmaceutica de liberacion inmediata | |
| DE69933885D1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
| AR032622A1 (es) | Compuestos de 4-amino-azepan-3-ona, composiciones farmaceuticas que los comprenden, intermediarios utiles en la sintesis de tales compuestos, procedimiento para la sintesis de dichos compuestos, y uso de tales compuestos en la fabricacion de medicamentos | |
| AR068372A1 (es) | Derivados de n-fenilacetamida, inhibidores de la enzima soat1, y composiciones farmaceuticas y cosmeticas que los contienen | |
| AR047409A1 (es) | Derivados ciclicos de fenilalanina, proceso de obtencion y composiciones farmaceuticas. | |
| AR044320A1 (es) | Derivados 3-decladinosilo de la clase de 9a - n-carbamoil - y 9a-ntiocarbamoil- 9 dihidro-9a aza- 9a - homoeritromicina a | |
| MY159418A (en) | New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use | |
| AR037498A1 (es) | Compuesto n-(4-amidino-2,6-difluorobenzil)-1-(2-(3-cloro-5-(difluorometoxi)fenil)-2-hidroxiacetil)azetidina-2-carboxamida y compuesto derivado del mismo, composicion farmaceutica, su uso en la preparacion de un medicamento y rutas sinteticas para su produccion | |
| DE602007003997D1 (de) | 3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |